Kalvista pharmaceuticals, inc. (KALV)
Income statement / TTM
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Sep'16Jul'16Jun'16Mar'16Jan'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Revenue

11,793

14,106

15,778

16,127

18,040

16,481

12,016

8,394

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

-

-

-

-

-

-

-

License Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29

-

29

29

-

29

29

32

30

29

0

0

0

Operating expenses:
Research and development

41,847

38,264

36,351

35,021

29,734

26,632

23,117

18,237

20,433

19,224

15,195

12,666

8,150

0

9,071

0

12,272

15,829

0

16,199

14,970

13,525

10,771

8,294

0

0

0

General and administrative

12,781

12,613

11,802

10,926

9,837

9,066

9,160

8,862

8,372

11,269

10,646

11,177

11,253

0

7,544

0

6,837

5,403

0

4,866

4,343

4,460

3,981

3,412

0

0

0

Restructuring and lease termination charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

Total operating expenses

54,628

50,877

48,153

45,947

39,571

35,698

32,277

27,099

25,385

27,073

22,421

23,843

24,283

0

21,495

0

23,989

22,692

0

21,065

19,313

17,985

14,752

11,706

0

0

0

Operating loss

-42,835

-36,771

-32,375

-29,820

-21,531

-19,217

-20,261

-18,705

-20,589

-24,360

-20,828

-22,339

-24,014

0

-21,466

0

-23,960

-22,663

0

-21,036

-19,284

-17,953

-14,722

-11,677

0

0

0

Other income:
Interest income

1,848

2,199

1,898

1,397

1,081

372

169

82

7

0

18

36

58

0

51

0

34

16

0

5

0

0

-

-

0

-

-

Foreign currency exchange gain

210

320

-471

49

346

-1,789

-1,475

-1,574

-2,016

-324

-55

1,371

2,848

0

-

0

-

-

0

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

581

-

677

440

-

1,188

1,662

1,924

1,838

1,082

0

0

0

Loss on extinguishment of convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Other income

9,843

8,653

7,948

7,682

7,157

6,409

5,660

4,392

4,074

3,750

2,884

2,329

659

0

-5

0

-5

-6

0

550

482

364

0

-

0

0

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total other income

11,901

11,172

9,375

9,128

8,584

4,992

4,354

2,900

1,438

2,799

2,578

3,736

0

0

-

0

-

-

0

-

-

-

-

-

-

0

0

Net loss

-31,058

-25,723

-23,124

-20,816

-12,947

-14,225

-15,907

-15,805

-16,372

-18,782

-16,181

-18,603

-23,986

0

-22,001

0

-24,607

-26,269

0

-24,846

-23,901

-22,905

-16,528

-13,359

0

0

0

Other comprehensive income (loss):
Foreign currency translation adjustments

515

276

-26

-1,257

-2,197

334

98

1,534

-5,874

-8,142

-6,774

-2,568

2,191

0

-

0

-

-

0

-

-

-

-

-

-

-

-

Unrealized holding gains on available-for-sale securities

328

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification adjustment for realized (gain) on available-for-sale securities included in net loss

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive income (loss)

0

0

0

-

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-30,339

-24,951

-22,682

-21,633

-14,912

-13,891

-15,809

-14,271

-25,249

-29,927

-26,868

-21,171

-14,137

0

-

0

-

-

0

-

-

-

-

-

-

-

-

Net loss attributable to common stockholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net loss per share to common stockholders, basic and diluted

-0.52

-0.33

-0.42

-0.46

-0.23

-0.22

-0.47

-0.03

-0.49

-0.50

-0.51

-3.07

-1.03

-5.98

-0.09

-6.66

-0.28

-0.25

-4.85

6.67

-0.19

-0.40

-7.38

-7.27

-5.89

-4.26

-4.39

Weighted average common shares outstanding, basic and diluted

17,838

17,823

17,488

17,183

17,231

15,108

10,799

10,781

10,788

10,003

9,713

-41,748

7,657

709

26,343

671

26,334

26,332

630

26,683

26,322

22,622

701

694

678

618

459